NanoViricides, Inc. is a biotechnology company based in West Haven, CT, that is dedicated to developing nanomachine-based antiviral therapeutics. Their innovative nanoviricides are designed to target specific viruses by fooling them into attaching to the nanomachine, which then wraps around the virus, neutralizing and destroying it without the need for immune system assistance. With a focus on advancing immunotherapeutics, NanoViricides aims to revolutionize antiviral strategies and bring about a new era in targeted antiviral therapeutics. NanoViricides, Inc. is at the forefront of nanomedicine technologies, with a team of experienced executives and scientists leading the way. Their nanoviricides have shown promising results in preclinical and clinical trials, demonstrating effectiveness against a range of viruses, including coronaviruses, respiratory syncytial virus (RSV), and varicella zoster virus (VZV). By leveraging their tailorable platform technology and dismantling approach, NanoViricides is poised to address unmet medical needs and potentially provide functional cures for various viral infections.
Generated from the website